HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 10, October 2021 – An Inquiry into Life in the Universe       » A New Cell Factory for High-Purity DHA Production       » A New Nanoplatform With Dual-Mode Therapeutic Pathways       » Improving Breast Cancer Detection With New Liquid Biopsy Diagnosis Model       » Alginic Acid: The Secret to Building Better Bones       » Next Generation Genome Engineering With Mini CRISPR — Made Smaller to Deliver Better      
NEWS CRUNCH
The Proteona Oncology Challenge using ESCAPETM
The Proteona Oncology Challenge using ESCAPE- Single Cell Proteogenomic Analysis

SINGAPORE, 23 September 2019 — Proteona Pte. Ltd has launched its first Proteona Oncology Challenge, co-sponsored by NovogeneAIT.

Proteona welcomes scientists and clinicians who are working the field of oncology to submit their abstracts on the use of ESCAPETM RNA-Seq single cell proteogenomic analysis services.

The winning submission will be awarded up to USD 50,000 worth of single cell analysis services from Proteona and NovogeneAIT, which will include ESCAPETM RNA-Seq single cell data acquisition and access to Proteona's AI analysis tools.

Even with the emergence of new approaches to cancer treatments such as, immunotherapy, and cell therapy, more research and development is needed to significantly improve clinical outcomes.

The challenge will be targeted at clinicians and scientists researching on utilising new technologies in single cell multi-omics analysis to address issues such as patient-to-patient variation, tumour heterogeneity, and identification of novel biomarkers that can aid in clinical decision-making.

"There are a lot of great ideas out there on how single cell multi-omics analysis can solve real clinical problems. We want to help putting them into action. By providing some additional resources, we hope to help clinical researches to get over the initial technical and financial barrier, so that they can make full use of this powerful tool to make a difference in future cancer treatment," says Dr. Andreas Schmidt, CEO of Proteona. "We will work very closely with the challenge winners and support them both on the wetlab and bioinformatics side."

Application is now open till the 1st of November 2019, full details of the grant challenge can be found at: www.proteona.com/Challenge.html

FORTHCOMING ISSUE  
Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific
NEWS CRUNCH  
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions
news A New Approach for Effective Gout Treatment
news TechInnovation Returns from 28 to 30 September 2021
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy